R
Rukiye Eker Omeroglu
Researcher at Istanbul University
Publications - 56
Citations - 505
Rukiye Eker Omeroglu is an academic researcher from Istanbul University. The author has contributed to research in topics: Familial Mediterranean fever & Cardiomyopathy. The author has an hindex of 12, co-authored 55 publications receiving 409 citations.
Papers
More filters
Journal ArticleDOI
Congenital heart disease in children with Down’s syndrome: Turkish experience of 13 years
Kemal Nisli,Naci Öner,Sukru Candan,Hülya Kayserili,Turkan Tansel,Emin Tireli,Birsen Karaman,Rukiye Eker Omeroglu,Aygün Dindar,Ümrah Aydoğan,Seher Başaran,Turkan Ertugrul +11 more
TL;DR: The first study concerning the frequency and type of CHD observed in Turkish children with DS implied that early screening for CHDs by echocardiography is crucial and correction of AVSDs in paediatric patients with DS should be performed in the first 6 months of life to avoid irreversible haemodynamic consequences of the defect.
Journal ArticleDOI
Ultrasonic evaluation of early atherosclerosis in children and adolescents with type 1 diabetes mellitus.
TL;DR: There is no association between type 1 diabetes mellitus and IMT in children and adolescents with T1DM, and statistical analysis indicated a good correlation between age and carotid arterial wall thickness in both diabetic and control groups.
Journal ArticleDOI
Relationship between clinical findings and genetic mutations in patients with familial Mediterranean fever.
Ayse Kilic,Muhammet Ali Varkal,Mehmet Sait Durmus,İsmail Yildiz,Zeynep Yuruk Yildirim,Gorkem Turunc,Fatma Oguz,Müjgan Sidal,Rukiye Eker Omeroglu,Sevinç Emre,Yasin Yilmaz,Fatih Mehmet Kelesoglu,Genco Gencay,Sonay Temurhan,Filiz Aydin,Emin Ünüvar +15 more
TL;DR: The most common mutation in children in Turkey with FMF is the M694V mutation, and most of the patients with proteinuria and elevated serum amyloid-A had homozygous M694v mutation.
Journal ArticleDOI
Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19.
Oya Koker,Fatma Gül Demirkan,Gülşah Kavrul Kayaalp,Figen Çakmak,Ayşe Tanatar,Şerife Gül Karadağ,Hafize Emine Sönmez,Rukiye Eker Omeroglu,Nuray Aktay Ayaz +8 more
TL;DR: Although circumstances such as compliance in social distancing policy, transmission patterns, attitude following contact may have influenced the results, immunosuppressive treatment does not seem to pose an additional risk in terms of COVID-19.
Journal Article
Left ventricular non-compaction in children and adolescents: clinical features, treatment and follow-up.
Yakup Ergül,Kemal Nisli,Atalay Demirel,Muhammed Ali Varkal,Naci Öner,Memduh Dursun,Aygün Dindar,Ümrah Aydoğan,Rukiye Eker Omeroglu +8 more
TL;DR: Closer study of patients with cardiomegaly and heart failure can reduce delays in diagnosis of LVNC, which can be diagnosed at any age from newborn to adolescent and has a variable clinical course.